Chinese Traditional and Herbal Drugs
|
2025, 56(7): 2385-2395
Mechanism of celastrol on inhibiting gastric cancer by regulating ferroptosis based on network pharmacology, molecular docking and experimental validation
Full
LIANG Shuang1, TANG Yuan1, LAN Tian1, LIN Yang1, DANG Chunyan2, WANG Ruilin1, MA Yuxiu1, PAN Haibang1, LI Hongling2
Affiliations
1 The First Clinical Medical School, Gansu University of Chinese Medicine, Lanzhou 730000, China;
2 Gansu Provincial Hospital, Lanzhou 730000, China
doi: 10.7501/j.issn.0253-2670.2025.07.015
Outline
Objective To investigate the mechanism of celastrol on inhibiting gastric cancer through regulating ferroptosis using network pharmacology, molecular docking and experimental validation. Methods Drug targets were collected from TCMSP and SwissTargetPrediction databases, while gastric cancer disease targets were obtained from Genecards, DrugBank, OMIM, TTD and PharmGKB databases. The intersection of these targets was identified using jvenn, followed by network visualization using STRING and Cytoscape 3.7.2 software. CytoNCA and CytoHubba plugins were used to calculate node scores and identify Hub genes. Gene ontology (GO) function and Kyoto encyclopedia of genes and genomes (KEGG) pathway enrichment analysis were performed using R software. Ferroptosis-related targets were retrieved from FerrDb V2, and the intersection with drug-disease targets was used to identify core targets. Molecular docking was carried out using SYBYL-X 2.0, RCSB, AutoDock Vina and Discovery Studio. AGS cells were cultured in vitro, and cell viability was measured using cell counting kit-8 (CCK-8). Cloning formation experiments and EdU experiments were used to investigate the effect of celastrol on cell proliferation. Scratch assays and Transwell assays were used to assess the effects of celastrol on cell migration. Flow cytometry was used to detect intracellular reactive oxygen species (ROS) levels. Fluorescence microscopy was used to observe mitochondrial membrane potential (MMP) changes. Kits were used to measure the levels of Fe2+, malondialdehyde (MDA) and glutathione/oxidized glutathione (GSH/GSSG). Western blotting was performed to determine the expression levels of key target and ferroptosis-related proteins. Results A total of 124 potential targets for celastrol and 2 343 gastric cancer-related targets were identified. The intersection of these targets revealed 89 common targets. Protein-protein interaction (PPI) network analysis identified 10 Hub genes. GO function enrichment analysis showed that celastrol mainly exerted its effects by influencing cell proliferation, transcription, apoptosis and oxidative stress. KEGG pathway enrichment analysis showed that celastrol was involved in regulating multiple tumor-related signaling pathways. A total of 25 common targets between celastrol, gastric cancer and ferroptosis were identified, signal transducer and activator of transcription 3 (STAT3) was determined as the core target through which celastrol regulateing ferroptosis in gastric cancer treatment based on docking score and PPI score. Molecular docking results indicated a strong binding affinity between celastrol and STAT3. Compared with control group, the viability, colony number, EdU positivity rate and cell migration rate of AGS cells in celastrol group were significantly decreased (P < 0.05, 0.01), ROS level was significantly increased (P < 0.01), MMP was significantly decreased (P < 0.01), levels of MDA and Fe2+ were significantly increased (P < 0.01), GSH/GSSG value was significantly decreased (P < 0.01), and showed a dose-dependent relationship. After intervention with ferrostatin-1 (Fer-1), the effects of celastrol on the above indicators were significantly reversed (P < 0.05, 0.01). Conclusion Celastrol induces ferroptosis in gastric cancer cells by regulating STAT3, inhibiting malignant proliferation and migration of gastric cancer cells.
celastrol
/
gastric cancer
/
network pharmacology
/
molecular docking
/
ferroptosis
/
signal transducer and activator of transcription 3
梁爽, 唐源, 兰天, 蔺阳, 党春艳, 王瑞麟, 马玉秀, 潘海邦, 李红玲.
基于网络药理学、分子对接及实验验证探讨雷公藤红素调控铁死亡抑制胃癌的作用机制.
中草药,
2025
, 56
(7)
: 2385
-2395
.
DOI: 10.7501/j.issn.0253-2670.2025.07.015
LIANG Shuang, TANG Yuan, LAN Tian, LIN Yang, DANG Chunyan, WANG Ruilin, MA Yuxiu, PAN Haibang, LI Hongling.
Mechanism of celastrol on inhibiting gastric cancer by regulating ferroptosis based on network pharmacology, molecular docking and experimental validation[J].
Chinese Traditional and Herbal Drugs,
2025
, 56
(7)
: 2385
-2395
.
DOI: 10.7501/j.issn.0253-2670.2025.07.015
Year 2025 volume 56 Issue 7
47
7
Cite this Article
BibTeX
Article Info
doi: 10.7501/j.issn.0253-2670.2025.07.015